In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis

Journal of Controlled Release

Volumn 94, Issue 1, 2004, Pages 25-37

  Schliecker, Gesine ^a,b   Schmidt, Carsten ^b   Fuchs, Stefan ^b   Ehinger, Andreas ^b   Sandow, Jürgen ^c   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Intervet Innovation GmbH   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Buserelin implants; IVIVC; Korsmeyer Peppas; Statistical moment analysis

Indexed keywords

BIODEGRADATION; CURVE FITTING; DISSOLUTION; DRUG DOSAGE; PARAMETER ESTIMATION; PHARMACOKINETICS;

DRUG RELEASES;

IMPLANTS (SURGICAL);

BUSERELIN;

AREA UNDER THE CURVE; ARTICLE; BIODEGRADABLE IMPLANT; COMPRESSION; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISSOLUTION; DRUG COATING; DRUG DIFFUSION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RELEASE; EROSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0346735303     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.09.003     Document Type: Article

References (36)

1. Morlock M., Koll H., Winter G., Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43:1997;29-36.
2. Cleland J.L., Duenas E., Daugherty A., Marian M., Yang J., Wilson M., Celniker A.C., Shahzamani A., Quarmby V., Chu H. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Release. 49:1997;193-205.
3. Rothen-Weinhold A., Besseghir K., De Zelicourt Y., Gurny R. Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue. J. Control. Release. 1-2:1998;205-213.
4. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28:1997;5-27.
5. Furr B.J.A., Hutchinson F.G. A biodegradable delivery system for peptides: preclinical experience with the gonadotrophine-releasing hormone agonist Zoladex. J. Control. Release. 21:1992;117-128.
6. Shah S., Cha Y., Pitt C. Poly(glycolic acid-co-DL-lactic acid): diffusion or degradation controlled drug delivery? J. Control. Release. 18:1992;261-270.
7. Hurrell S., Cameron R.E. The effect of initial polymer morphology on the degradation and drug release from polyglycolide. Biomaterials. 23:2002;2401-2409.
8. Kader A., Jalil R. Formulation factors affecting drug release from poly(lactic acid) (PLA) microcapsule tablets. Drug Dev. Ind. Pharm. 25:1999;141-151.
9. Park T.G. Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight. J. Control. Release. 30:1994;161-173.
10. Rothen-Weinhold A., Besseghir K., Gurny R. Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue. Eur. J. Pharm. Sci. 5:1997;303-313.
11. Shah V., Siewert M., Dressman J., Moeller H., Brown C.K. Dissolution/in vitro release testing of special dosage forms. Dissolution Technol. 9:2002;1-5.
12. Dash A.K., Haney P.W., Garavalia M.J. Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems. J. Pharm. Sci. 88:1999;1036-1040.
13. Woo B.H., Kostanski W., Gebrekidan S., Dani B.A., Thanoo B.C., DeLuca P.P. Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres. J. Control. Release. 75:2001;307-315.
14. Uppoor V. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J. Control. Release. 72:2001;127-132.
15. USP 26/NF 21, Pharmacopial Convention, Rockville, 2003.
16. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 24:1972;979-981.
17. Wagner J.G., Nelson E. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug. J. Pharm. Sci. 53:1964;1392-1403.
18. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52:1963;1145-1149.
19. Korsmeyer R.W., Gurny R., Doelker E.M., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 15:1983;25-35.
20. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:1985;110-111.
21. 10 LHRH (Buserelin) in the management of precocious puperty. Labrie F., Belanger A., Dupont A. LHRH and its Analogues. 1984;407-424 Elsevier, Amsterdam.
22. Gibaldi M., Perrier D. Noncompartmental analysis based on statistical moment theory. Dekker M. Pharmacokinetics. 1982;409-417 Marcel Dekker Inc. New York.
23. Sandow J., Jerabek-Sandow G., Krauss B., Schmidt-Gollwitzer M. Pharmacokinetics and metabolism of LHRH agonists, clinical aspects. Labrie F., Belanger A., Dupont A. LHRH and its Analogues. 1984;123-137 Elsevier, Amsterdam.
24. Mojaverian P., Rosen J., Vadino W.A., Liebowitz S., Radwanski E. In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate. J. Pharm. Biomed. Anal. 15:1997;439-445.
25. Brockmeier D., Voegele D., von Hattingberg H.M. In vitro-in vivo correlation, a time scaling problem? Arzneim.-Forsch. 33:1983;598-601.
26. Bodmer D., Kissel T., Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Control. Release. 21:1992;129-138.
27. Chiu L.K., Chiu W.J., Cheng Y.L. Effects of polymer degradation on drug release - a mechanistic study of morphology and transport properties in 50:50 poly(DL-lactide-co-glycolide). Int. J. Pharm. 126:1995;169-178.
28. Narasimhan B., Peppas N.A. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier. J. Pharm. Sci. 86:1997;297-304.
29. Holland S.J., Tighe B.J., Goulg P.L. Polymers for biodegradable medical devices: 1. The potential of polyesters as controlled macromolecular release systems. J. Control. Release. 4:1986;155-180.
30. Leuenberger H., Holman L., Usteri M., Winzap S. Percolation theory, fractal geometry and dosage form. Acta Helv. 64:1989;34-39.
31. Bonny J.D., Leuenberger H. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics. Pharm. Acta Helv. 66:1991;160-164.
32. Baro M., Sanchez E., Delgado A., Perera A., Evora C. In vitro-in vivo characterization of gentamicine bone implants. J. Control. Release. 83:2002;353-364.
33. Vandamme T.F., Ngombo Mukendi J.F. Controlled release of levamisole from poly(epsilon-caprolactone) matrices: III. Effect of molecular weight and polymer coating on drug release. Int. J. Pharm. 145:1996;77-86.
34. Volland C., Wolff M., Kissel T. The influence of terminal gamma-sterilization on captopril containing poly(D,L-lactide-co-glycolide) microspheres. J. Control. Release. 31:1994;293-305.
35. Sandow J., Jerabek-Sandow G., Krauss B., von Rechenberg W. Pharmacokinetic and antigenicity studies with LHRH analogues. Runnebaum B., Rabe T., Kiesel L. Future Aspects in Contraception, Part 2, Female Contraception. 1985;129-147 MTP Press Ltd. Boston.
36. Sandow J., Fraser H.M., Seidel H., Krauss B., Jerabek-Sandow G., von Rechenberg W. Buserelin: pharmacokinetics, metabolism and mechanisms of action. Br. J. Clin. Pract. 41:1987;6-13.